Ticker brief

AVTX AVALO THERAPEUTICS INC

Consumer, Non-cyclical · Biotechnology

last close
$18.53
1 day
+2.7%
14 days
-1.5%
mkt cap
$990.3M
signals 14d
8
authors 14d
4
crowd 14d
-0.4σ
Options inteloptions-surface reads · latest available day per source
metricreadingcontext
IV — ATM 30d85%IV/HV 1.18× (as of 2026-07-02)
Skew — 25Δ RR 30d+0.02525Δ call IV − put IV
Net dealer OI (NDOI)+0.26 thin5-session Δ n/a (as of 2026-07-02)
OI alarmquietlast alarm 2026-05-07 (z=2.2)
Sentiment — last 14 days
daily mean sentiment, 2026-08-19 → 2026-08-27 · now +0.33 (−1 bearish … +1 bullish)
Who spoke4
authorgradetrader scoresignalsmean sent
@scetraderC+1.594-0.10
@SandmanMarketsC-2.912+0.40
@kkernttbC-2.191+0.50
@oratnek_illC+0.701+0.20
Recent signals8of 8 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-08-27@SandmanMarkets+0.80Enter AVTX at the open, add at $18.95, and stop below $17.23. — Provides explicit long entries and a stop after moving-average reclaims and an OBV breakout.
2026-08-27@SandmanMarkets+0.00Lists four watchlist names and points to a setup thread without stating entries here.
2026-08-27@oratnek_ill+0.20Daily watchlist categorizes stocks by pivot, trend-line-break, and volume structures without entry intent.
2026-08-24@scetrader-0.70Says Avantium has sufficient technology but shareholders are being drained.
2026-08-21@scetrader+0.00Podcast headline says AEX holds 1100 and references charts for several assets.
2026-08-20@kkernttb+0.50Positively highlights a strong AVTX price move.
2026-08-19@scetrader+0.15Describes neutral trading conditions with some chance of a rise.
2026-08-19@scetrader+0.15Notes AVTX weakness while suggesting a possible broader rally.

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.